Pharmaceutical and immunological evaluation of human papillomavirus viruslike particle as an antigen carrier

This publication has 30 references indexed in Scilit:

• Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys
  Vaccine, 2004
• Potential of Lipid Core Peptide Technology as a Novel Self-Adjuvanting Vaccine Delivery System for Multiple Different Synthetic Peptide Immunogens
  Infection and Immunity, 2003
• Old and new vaccine approaches
  International Immunopharmacology, 2003
• Induction of specific T-helper and cytolytic responses to epitopes displayed on a virus-like protein scaffold derived from the pyruvate dehydrogenase multienzyme complex
  Vaccine, 2002
• Evaluation of HBs, HBc, and frCP virus-like particles for expression of human papillomavirus 16 E7 oncoprotein epitopes.
  Intervirology, 2002
• Chimeric Recombinant Hepatitis E Virus-like Particles as an Oral Vaccine Vehicle Presenting Foreign Epitopes
  Virology, 2002
• Comparison of phage pIII, pVIII and GST as carrier proteins for peptide immunisation in Balb/c mice
  Immunology Letters, 2001
• Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies
  Journal of Clinical Investigation, 2001
• Formation of Immunogenic Virus-like Particles by Inserting Epitopes into Surface-Exposed Regions of Hamster Polyomavirus Major Capsid Protein
  Virology, 2000
• Highly immunogenic and fully synthetic peptide-carrier constructs targetting GNRH
  Vaccine, 1999